Cizzle Biotechnology Holdings plc (CIZ)

PriceLoading quote
CIZLondon Stock Exchange
Loading local price history

Financial charts

Net income

Total cash / debt

CashTotal debt

Financial statements

4 annual periodsNewest to oldest
2025202420232022
Revenue£0£0£0£0
Research & development£234,000£213,000£214,000£280,000
Operating expenses£731,000£878,000£976,000£963,000
Operating income−£731,000−£878,000−£976,000−£963,000
EBITDA−£731,000−£878,000−£976,000−£963,000
Net income−£691,000−£2.2M−£1.7M−£912,000
Basic EPSper basic share-£0.00-£0.01-£0.01-£0.00
Diluted EPSper diluted share-£0.00-£0.01-£0.01-£0.00

Community posts

It’s quiet here.

No posts about CIZ yet. Start the conversation.

Write the first post